Can the pharmacogenetics of GST gene polymorphisms predict the dose of busulfan in pediatric hematopoietic stem cell transplantation?

Pharmacogenomics. 2009 Nov;10(11):1729-32. doi: 10.2217/pgs.09.135.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Alkylating / administration & dosage*
  • Busulfan / administration & dosage*
  • Busulfan / adverse effects
  • Child
  • Glutathione Transferase / genetics*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Pharmacogenetics*
  • Polymorphism, Genetic*

Substances

  • Antineoplastic Agents, Alkylating
  • Glutathione Transferase
  • Busulfan